Literature DB >> 19308889

Milestones and perspectives in coagulation and hemostasis.

Giuseppe Lippi1, Emmanuel J Favaloro, Massimo Franchini, Gian Cesare Guidi.   

Abstract

Hemostasis is traditionally defined as the physiologic process whereby bleeding is antagonized and possibly stopped to minimize blood loss. The first medical description of the clinical and inherited features of hemostasis can be dated back more than 1000 years, when Abu al-Qasim Khalaf ibn 'Abbas al-Andalusi al-Zahrawi' medical treatise provided some initial insights into this puzzling process. Since then, continuous and revolutionary scientific developments have contributed to decoding several aspects of this intricate but essential physiologic phenomenon, providing a reliable model to explain the leading mechanisms involved. Although the point at which bleeding stops is commonly referred to as "coagulation," blood coagulation is actually only one part of a two-part hemostatic process that develops through sequential steps referred to as primary and secondary hemostasis. Throughout its activation and development, the coagulation cascade is strictly regulated by a series of natural inhibitors, which prevent unnecessary and excessive clotting. The aim of this article is to provide a concise overview of the major discoveries and past and current perspectives in coagulation and hemostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308889     DOI: 10.1055/s-0029-1214144

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  9 in total

1.  A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium.

Authors:  Kira C Taylor; Leslie A Lange; Delilah Zabaneh; Ethan Lange; Brendan J Keating; Weihong Tang; Nicholas L Smith; Joseph A Delaney; Meena Kumari; Aroon Hingorani; Kari E North; Mika Kivimaki; Russell P Tracy; Christopher J O'Donnell; Aaron R Folsom; David Green; Steve E Humphries; Alexander P Reiner
Journal:  Hum Mol Genet       Date:  2011-06-15       Impact factor: 6.150

2.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin.

Authors:  Roberto P Santos; Ana M F Tovar; Marcos R Oliveira; Adriana A Piquet; Nina V Capillé; Stephan N M C G Oliveira; Ana H Correia; José N Farias; Eduardo Vilanova; Paulo A S Mourão
Journal:  TH Open       Date:  2022-05-26

Review 5.  Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population.

Authors:  Anubhuti Saha; Ashutosh Bajpai; Vinay Krishna; Shantanu Bhattacharya
Journal:  Sensors (Basel)       Date:  2021-04-09       Impact factor: 3.576

6.  Development of an Optical Method for the Evaluation of Whole Blood Coagulation.

Authors:  Marinos Louka; Efstathios Kaliviotis
Journal:  Biosensors (Basel)       Date:  2021-04-09

7.  Hemostatic Effect of 20(S)-Panaxadiol by Induced Platelet Aggregation Depending on Calcium Signaling Pathway.

Authors:  He Zhang; Yuyao Zhang; Xiaolei Tang; Wenjie Su; Chunhui Yang; Daian Pan; Daqing Zhao; Bin Qi; Xiangyan Li
Journal:  Biomed Res Int       Date:  2022-09-20       Impact factor: 3.246

Review 8.  The new oral anticoagulants and the future of haemostasis laboratory testing.

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

9.  The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.

Authors:  Kerstin Göbel; Susann Eichler; Heinz Wiendl; Triantafyllos Chavakis; Christoph Kleinschnitz; Sven G Meuth
Journal:  Front Immunol       Date:  2018-07-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.